Dormant Company Accounts - HAELAN PHARMACEUTICALS LIMITED

Dormant Company Accounts - HAELAN PHARMACEUTICALS LIMITED


Companies House true 2020-12-03 2021-12-31 false 13060328 uk-bus:Director1 2020-12-03 2021-12-31 13060328 uk-bus:Director2 2020-12-03 2021-12-31 13060328 2020-12-03 2021-12-31 13060328 2021-12-31 13060328 uk-bus:EntityHasNeverTraded 2020-12-03 2021-12-31 13060328 uk-bus:FRS102 2020-12-03 2021-12-31 13060328 uk-bus:FullAccounts 2020-12-03 2021-12-31 13060328 uk-bus:AuditExempt-NoAccountantsReport 2020-12-03 2021-12-31 13060328 uk-bus:OrdinaryShareClass1 2020-12-03 2021-12-31 13060328 uk-bus:OrdinaryShareClass2 2020-12-03 2021-12-31 13060328 uk-bus:OrdinaryShareClass3 2020-12-03 2021-12-31 13060328 uk-bus:PreferenceShareClass1 2020-12-03 2021-12-31 13060328 uk-bus:PreferenceShareClass2 2020-12-03 2021-12-31 13060328 uk-bus:PreferenceShareClass3 2020-12-03 2021-12-31 13060328 uk-core:ShareCapitalPreferenceShares 2021-12-31 iso4217:GBP xbrli:shares

Registered Number 13060328

HAELAN PHARMACEUTICALS LIMITED

Dormant Accounts

31 December 2021

HAELAN PHARMACEUTICALS LIMITED Registered Number 13060328

Balance Sheet as at 31 December 2021

2021
£
Called up share capital not paid
1600
Net assets
1600
Issued share capital
1600 Ordinary Shares of £ 1 each 1600
Total Shareholder funds
1600

STATEMENTS

  1. For the year ending 31 December 2021 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 2 September 2022

And signed on their behalf by:
Dawn Dowds, Director